Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Gp41-1 split intein is a highly efficient protein splicing element derived from a cyanophage, consisting of N-terminal (IntN) and C-terminal (IntC) fragments. These fragments possess a high affinity for one another and, upon association, catalyze a self-excision process known as protein trans-splicing, which covalently links two flanking protein sequences (exteins) with a native peptide bond (PMID: 23933386, PMID: 21534051). In biotechnology and medicine, Gp41-1 is primarily utilized as a tool for protein engineering and gene therapy rather than serving as a traditional therapeutic target. It is frequently employed to circumvent the packaging limits of viral vectors, such as Adeno-associated virus (AAV), by splitting large therapeutic proteins into two halves that reconstitute functionally within the target cell (PMID: 31586043). While it is not a target for small molecule drugs, its kinetics and specificity make it a cornerstone of synthetic biology for the conditional activation of enzymes, transcription factors, and chimeric antigen receptors (CARs).
The Gp41-1 split intein fragments (IntN and IntC) undergo rapid and spontaneous association to form a functional catalytic domain that facilitates protein trans-splicing, resulting in the excision of the intein and the ligation of flanking extein sequences via a peptide bond (PMID: 23933386).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gp41-1 split intein (Gp41-1).